Massive study reveals who gets key heart failure drugs
NCT ID NCT07022379
Summary
This study looked back at the medical records of over 13,600 heart failure patients in France from 2021 to 2024. It tracked how often doctors prescribed a specific type of medication called SGLT2 inhibitors. The goal was to understand prescription trends and what factors influenced which patients received this treatment as part of their regular care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NP Medical
Bordeaux, 33000, France
Conditions
Explore the condition pages connected to this study.